Quagliariello, V.; Di Mauro, A.; Ferrara, G.; Bruzzese, F.; Palma, G.; Luciano, A.; Canale, M.L.; Bisceglia, I.; Iovine, M.; Cadeddu Dessalvi, C.;
et al. Cardio–Renal and Systemic Effects of SGLT2i Dapagliflozin on Short-Term Anthracycline and HER-2-Blocking Agent Therapy-Induced Cardiotoxicity. Antioxidants 2025, 14, 612.
https://doi.org/10.3390/antiox14050612
AMA Style
Quagliariello V, Di Mauro A, Ferrara G, Bruzzese F, Palma G, Luciano A, Canale ML, Bisceglia I, Iovine M, Cadeddu Dessalvi C,
et al. Cardio–Renal and Systemic Effects of SGLT2i Dapagliflozin on Short-Term Anthracycline and HER-2-Blocking Agent Therapy-Induced Cardiotoxicity. Antioxidants. 2025; 14(5):612.
https://doi.org/10.3390/antiox14050612
Chicago/Turabian Style
Quagliariello, Vincenzo, Annabella Di Mauro, Gerardo Ferrara, Francesca Bruzzese, Giuseppe Palma, Antonio Luciano, Maria Laura Canale, Irma Bisceglia, Martina Iovine, Christian Cadeddu Dessalvi,
and et al. 2025. "Cardio–Renal and Systemic Effects of SGLT2i Dapagliflozin on Short-Term Anthracycline and HER-2-Blocking Agent Therapy-Induced Cardiotoxicity" Antioxidants 14, no. 5: 612.
https://doi.org/10.3390/antiox14050612
APA Style
Quagliariello, V., Di Mauro, A., Ferrara, G., Bruzzese, F., Palma, G., Luciano, A., Canale, M. L., Bisceglia, I., Iovine, M., Cadeddu Dessalvi, C., Maurea, C., Barbato, M., Inno, A., Berretta, M., Paccone, A., Mauriello, A., Fonderico, C., Maratea, A. C., & Maurea, N.
(2025). Cardio–Renal and Systemic Effects of SGLT2i Dapagliflozin on Short-Term Anthracycline and HER-2-Blocking Agent Therapy-Induced Cardiotoxicity. Antioxidants, 14(5), 612.
https://doi.org/10.3390/antiox14050612
